Acta Med. 2022, 65: 25-28
Efficacy of Prednisone in Children with Acute Nonspecific Mesenteric Lymphadenitis: A Pilot Study
, Zeljko Rokvicb, Karolina Berenjic
aChildren’s Ambulatory Care Center, Subotica, Serbia
bDepartment of Diagnostic Imaging, General Hospital Subotica, Serbia
cDepartment of Hygiene and Human Ecology, Public Health Institute, Subotica, Serbia
Received November 25, 2020
Accepted April 22, 2022
Background: Acute nonspecific mesenteric lymphadenitis (ANML) is a common cause of acute abdominal pain in children with no specific treatment. Methods: A total of 13 patients (6 boys, 7 girls) aged 7.3 (5–13.5) years with severe acute abdominal pain were evaluated using ultrasonography and laboratory tests to establish the diagnosis of ANML. They were treated with prednisone 1 mg/kg (max 40 mg daily) for a maximum of 5 days. The intensity of abdominal pain was evaluated before and after treatment using a numeric rating scale. Results: All patients had pain scores above 6/10 before, and below 4/10 after treatment with prednisone. Intensity of abdominal pain after treatment for 1–5 days decreased significantly (p < 0.001), with no recurrence at follow-up within 3 months. All other pre-existing signs and symptoms, such as nausea, vomiting, anorexia, fever, diarrhea, and constipation were found to disappear with no adverse effects of corticosteroid therapy. Conclusion: These results suggest that the treatment with prednisone in selective patients with ANML can reduce the duration of abdominal pain.
Keywords
mesenteric lymphadenitis, corticosteroids, abdominal pain, children, lymphoma.
References
Copyright
This is an open-access article distributed under the terms of the Creative Commons Attribution License.
